Testing effectiveness (Phase 2)Looking for participantsNCT05990192
What this trial is testing
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Who this might be right for
Ovarian Cancer Recurrent
Institute of Cancer Research, United Kingdom 42